Status:
COMPLETED
Quality of Life and Treatment Satisfaction of People With Type 2 Diabetes: A European Survey
Lead Sponsor:
AstraZeneca
Conditions:
Diabetes
Eligibility:
All Genders
40+ years
Brief Summary
The present European survey seeks to assess quality of life and satisfaction with treatment in people with T2DM and to appreciate disease and treatment variables including hypoglycaemia and level of g...
Eligibility Criteria
Inclusion
- With T2DM, diagnosed at least 1 year prior to entry in the study
- Currently treated with diet, OAD(s) and/or insulin with no change in the type of OAD(s) or insulin in the previous three months
Exclusion
- Type 1 diabetes and/or history of diabetic ketoacidosis
- Secondary diabetes (including disease of the exocrine pancreas, endocrinopathies or drug-induced)
- Treatment with systemic glucocorticoids other than replacement therapy. Inhaled, local injected and topical use of glucocorticoids is allowed
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
5926 Patients enrolled
Trial Details
Trial ID
NCT00916513
Start Date
May 1 2009
End Date
March 1 2010
Last Update
April 27 2010
Active Locations (302)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Antibes, France
2
Research Site
Athies, France
3
Research Site
Audruicq, France
4
Research Site
Auxerre, France